Bivalent Fv antibody fragments obtained by substituting the constant domains of a fab fragment with heterotetrameric molybdopterin synthase

Journal of Molecular Biology

Volumn 341, Issue 4, 2004, Pages 1039-1048

  Petrov, Kliment ^a,b   Dion, Michel ^a   Hoffmann, Lionel ^a   Dintinger, Thierry ^a   Defontaine, Alain ^a   Tellier, Charles ^a  

^a Biocatalyse Bioregulation Fac S   (France)

^b UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

antibody engineering; bivalency; catalytic antibodies; Fv fragments; MPTS

Indexed keywords

FV ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; MOLYBDOPTERIN; MOLYBDOPTERIN SYNTHASE; PEPTIDE; SYNTHETASE; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOPLASM; ESCHERICHIA COLI; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; TITRIMETRY;

ESCHERICHIA COLI;

EID: 3843109039     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.06.075     Document Type: Article

References (32)

1. W. Dall'Acqua, and P. Carter Antibody engineering Curr. Opin. Struct. Biol. 8 1998 443 450
2. P.J. Hudson Recombinant antibody constructs in cancer therapy Curr. Opin. Immunol. 11 1999 548 557
3. D. Givol The minimal antigen-binding fragment of antibodies - Fv fragment Mol. Immunol. 28 1991 1379 1386
4. W.D. Mallender, J. Carrero, and E.W. Voss Jr Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand J. Biol. Chem. 271 1996 5338 5346
5. R.E. Bird, K.D. Hardman, J.W. Jacobson, S. Johnson, B.M. Kaufman, and S.M. Lee Single-chain antigen-binding proteins Science 242 1988 423 426
6. Y. Reiter, U. Brinkmann, K.O. Webber, S.H. Jung, B. Lee, and I. Pastan Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv Protein Eng. 7 1994 697 704
7. Y. Reiter, U. Brinkmann, B. Lee, and I. Pastan Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments Nature Biotechnol. 14 1996 1239 1245
8. B. Wang, Y.B. Chen, O. Ayalon, J. Bender, and A. Garen Human single-chain Fv immunoconjugates targeted to a melanoma-associated chondroitin sulfate proteoglycan mediate specific lysis of human melanoma cells by natural killer cells and complement Proc. Natl Acad. Sci. USA 96 1999 1627 1632
9. S. Hu, L. Shively, A. Raubitschek, M. Sherman, L.E. Williams, and J.Y. Wong Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts Cancer Res. 56 1996 3055 3061
10. P. Pack, and A. Pluckthun Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli Biochemistry 31 1992 1579 1584
11. P. Pack, M. Kujau, V. Schroeckh, U. Knupfer, R. Wenderoth, D. Riesenberg, and A. Pluckthun Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli Biotechnology (NY) 11 1993 1271 1277
12. P. Holliger, T. Prospero, and G. Winter "Diabodies": small bivalent and bispecific antibody fragments Proc. Natl Acad. Sci. USA 90 1993 6444 6448
13. A. Worn, and A. Pluckthun Stability engineering of antibody single-chain Fv fragments J. Mol. Biol. 305 2001 989 1010
14. P.J. Hudson, and A.A. Kortt High avidity scFv multimers; diabodies and triabodies J. Immunol. Methods 231 1999 177 189
15. D.M. Pitterle, and K.V. Rajagopalan The biosynthesis of molybdopterin in Escherichia coli. Purification and characterization of the converting factor J. Biol. Chem. 268 1993 13499 13505
16. D.M. Pitterle, J.L. Johnson, and K.V. Rajagopalan In vitro synthesis of molybdopterin from precursor Z using purified converting factor. Role of protein-bound sulfur in formation of the dithiolene J. Biol. Chem. 268 1993 13506 13509
17. M.J. Rudolph, M.M. Wuebbens, K.V. Rajagopalan, and H. Schindelin Crystal structure of molybdopterin synthase and its evolutionary relationship to ubiquitin activation Nature Struct. Biol. 8 2001 42 46
18. M.J. Rudolph, M.M. Wuebbens, O. Turque, K.V. Rajagopalan, and H. Schindelin Structural studies of molybdopterin synthase provide insights into its catalytic mechanism J. Biol. Chem. 278 2003 14514 14522
19. S. Robin, K. Petrov, T. Dintinger, A. Kujumdzieva, C. Tellier, and M. Dion Comparison of three microbial hosts for the expression of an active catalytic scFv Mol. Immunol. 39 2003 729 738
20. B. Golinelli-Pimpaneau, O. Goncalves, T. Dintinger, D. Blanchard, M. Knossow, and C. Tellier Structural evidence for a programmed general base in the active site of a catalytic antibody Proc. Natl Acad. Sci. USA 97 2000 9892 9895
21. O. Goncalves, T. Dintinger, J. Lebreton, D. Blanchard, and C. Tellier Mechanism of an antibody-catalysed allylic isomerization Biochem. J. 346 2000 691 698
22. E.A. Kabat, and T.T. Wu Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites J. Immunol. 147 1991 1709 1719
23. P.H. Bessette, F. Aslund, J. Beckwith, and G. Georgiou Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm Proc. Natl Acad. Sci. USA 96 1999 13703 13708
24. S. Leimkuhler, M.M. Wuebbens, and K.V. Rajagopalan Characterization of Escherichia coli MoeB and its involvement in the activation of molybdopterin synthase for the biosynthesis of the molybdenum cofactor J. Biol. Chem. 276 2001 34695 34701
25. A. GenreGrandpierre, C. Tellier, M.J. Loirat, D. Blanchard, D.R.W. Hodgson, F. Hollfelder, and A.J. Kirby Catalysis of the Kemp elimination by antibodies elicited against a cationic hapten Bioorg. Med. Chem. Letters 7 1997 2497 2502
26. M. Jager, and A. Pluckthun Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria FEBS Letters 462 1999 307 312
27. K.M. Arndt, K.M. Muller, and A. Pluckthun Helix-stabilized Fv (hsFv) antibody fragments: substituting the constant domains of a Fab fragment for a heterodimeric coiled-coil domain J. Mol. Biol. 312 2001 221 228
28. A. Pluckthun, and P. Pack New protein engineering approaches to multivalent and bispecific antibody fragments Immunotechnology 3 1997 83 105
29. J.A. Carmichael, B.E. Power, T.P. Garrett, P.J. Yazaki, J.E. Shively, and A.A. Raubischek The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility J. Mol. Biol. 326 2003 341 351
30. O. Perisic, P.A. Webb, P. Holliger, G. Winter, and R.L. Williams Crystal structure of a diabody, a bivalent antibody fragment Structure 2 1994 1217 1226
31. J.B. Pitner, W.F. Beyer, T.M. Venetta, C. Nycz, M.J. Mitchell, and S.L. Harris Bivalency and epitope specificity of a high-affinity IgG3 monoclonal antibody to the Streptococcus group A carbohydrate antigen. Molecular modeling of a Fv fragment Carbohydr. Res. 324 2000 17 29
32. B. Stallmeyer, G. Drugeon, J. Reiss, A.L. Haenni, and R.R. Mendel Human molybdopterin synthase gene: identification of a bicistronic transcript with overlapping reading frames Am. J. Hum. Genet. 64 1999 698 705